The North American anticoccidial drugs market size is estimated to grow from USD 393.18 Million in 2021 to USD 462.26 Million by 2026, at a CAGR of 3.29%.
The increasing consumption rate of meat and poultry products is a significant factor in setting up growth opportunities for the Anticoccidial Drugs market in the North America region. Anticoccidial drugs are used in animal feed to supply required nutrients and minerals for the animals. It is essential to maintain a healthy diet for the animals to improve the quality of the products. This factor is significantly influencing the demand of the market.
Growing prevalence to increase the productivity in pharmaceutical companies is also lavishing the growth of the market. Coccidiosis is a parasitic disease caused by single-celled parasites and affects the animals' health in various ways.
Anticoccidial drugs are the treatment procedure for the animals to get rid of those diseases, which lavishes the market demand. Increasing research and development institutes in manufacturing quality products at a relatively low cost is surging the market's growth rate in North America.
Increasing prevalence in using organic products in producing the drugs greatly influences the demand of the market. The rise in the incidences of various infectious diseases is also fueling the need for the market. Increasing the scale of pharmaceutical companies to increase revenue is also to expand the demand of the market.
This report on the North American Anticoccidial Drugs Market has been segmented and sub-segmented into the following categories:
By Drug Type:
By Animal Type:
Regionally, North America leads the global anticoccidial drugs market due to increased preventive use of anticoccidials in animal feed. It contributes to around 24% of the global anticoccidial drug market.
The U.S is witnessed in holding dominant shares of the market owing to the quick adoption of the latest technologies. Increasing demand to ensure the quality of the poultry products and increasing production rate is prompting the market's need in this region. Also, the rise in support from the government through investments in pharmaceutical companies broadens the market demand. Canada is following the U.S in dominating shares of the market. Increasing the livestock population is a primary factor for the market to grow in this country. Rising prevalence to meet meat products' requirements with high quality is ascribed to bolster the market's growth rate in this region.
Additionally, growing disposable income in urban areas is leveraging the growth rate of the market. Increasing awareness over the availability of drugs and their usage positively impacts the growth of the market. Mexico is having a significant growth rate from the past few years and is also anticipated to have the same flow in the coming years. Changes in the lifestyles and demand for protein foods like milk and others broaden the market's need.
Currently, the industry's major players face complications with the rising incidences of microbial resistance build-up to anticoccidial drugs and government regulations in developed regions, which is compelling them to invest in emerging markets.
Some of the key players operating in the North American anticoccidial drugs market are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Drug Type
5.1.1 Antibiotic anticoccidials
5.1.2 Ionophore anticoccidials
5.1.3 Chemical derivative anticoccidials
5.2 By Animal Type
5.2.5 Companion Animal
6. Geographical Analysis
6.1 North America
6.1.2 United States
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Bayer Health care
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.4 Merck Animal Healthcare
8.6 Ceva Santé Animale
8.7 Boehringer Ingelheim Animal Health
8.8 Novartis Animal Healthcare
8.9 Smartvet Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
a) List of Tables
b) List of Figures